KindlyMD, Inc. NAKA

9.99 0.23 2.36% as of 25 Sep
Market cap
$177.2M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 1.23
Total sells 0.01
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — 2 — — 2 —
Sell — — — — — — — — — — — 1
Insider Ownership 44.50%

Capital & Financial Ratios

Market Cap 177.16
Revenue 39.79
Net Income (420.55)
Free Cash Flow (687.94)
Net Debt (19.07)
Current Ratio 0.15
Debt/Equity 0.00
P/E ratio 0.00
P/S ratio 5.02
P/B ratio 0.85
Past 5Y EPS Growth —
This Y EPS Growth 23.94%
Next Y EPS Growth 86.89%
Next 5Y EPS Growth 62.35%
in millions of $

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 1 2 23 19
Receivables 0 0 — —
Inventory 0 0 — —
Other — — 199 4
1 3 224 27
2023 2024 2025 Q'26
Payables 0 0 6 11
ST’ Debt — — — —
Other 0 0 1 4
1 1 216 179
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — —
Cash Flow — — —
Earnings — — —
Book Value — — —

Revenue

Mar Jun Sep Dec Year
’26 3 36 — — —
’25 1 0 0 1 2
’24 1 1 1 1 3
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (23) (3) — — —
’25 (1) (2) (13) (8) (24)
’24 0 (1) (1) (1) (3)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (7) (5) — — —
’25 (1) (4) (655) (21) (679)
’24 0 (1) (1) (1) (3)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (15.20) (6.65) — — —
’25 (6.80) (14.00) (16.80) 2.80 (10.40)
’24 (2.40) (10.40) (6.80) (6.80) (26.80)
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — — — — — 26.00 13.72

Analyst estimates 2026–2028

Powerpack
Low Price
— — — — — — — — 168.00 1,390.80
High Price
— — — — — — — — 61 65
Employees
— — — — — — — 0 0 0
Revenue/Emp
— — — — — — — 4 3 2
Revenue
— — — — — — — 94.00% 100.00% 100.00%
Gross Margin
— — — — — — — (2) (4) (52)
EBT
— — — — — — — (42.92%) (133.01%) (2,867.67%)
EBT Margin
— — — — — — — (2) (4) (52)
Net Income
— — — — — — — 0 1 3
Depreciation
— — — — — — — 33.50 20.18 0.36
Revenue/Sh
— — — — — — — (14.38) (26.80) (10.40)
Earnings/Sh
— — — — — — — (4.00) (22.80) (4.70)
Cash Flow/Sh
— — — — — — — (0.13) (2.98) (130.92)
Capex/Sh
— — — — — — — (4.12) (25.78) (135.62)
Free CF/Sh
— — — — — — — (0.96) 19.05 102.75
Book Value/Sh
— — — — — — — 0 0 5
Shares
— — — — — — — 0.00 0.00 0.00
PE Ratio
— — — — — — — 4.06 2.46 31.51
PS Ratio
— — — — — — — 0.00 2.60 0.14
PB Ratio
— — — — — — — 4.02 1.63 22.07
EV/Sales
— — — — — — — (16.42) (1.27) (0.07)
EV/FCF
— — — — — — — 0 (3) (24)
Op' Cash Flow
— — — — — — — 0 0 (655)
Capex
— — — — — — — 0 (3) (679)
FCF
— — — — — — — 0 2 8
Working Cap'
— — — — — — — 0 0 —
Total Debt
— — — — — — — 0 (2) (23)
Net Debt
— — — — — — — 0 3 514
Sh' Equity
— — — — — — — 0.00% (151.45%) (14.23%)
ROA
— — — — — — — 0.00% (691.95%) (25.06%)
ROIC
— — — — — — — 0.00% (294.13%) (20.21%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

KindlyMD, Inc. peers in Capital Markets

All 93 Capital Markets stocks →

KindlyMD, Inc. (NAKA) key facts

  • KindlyMD, Inc. (NAKA) is a Capital Markets company in the Financial sector, listed on Nasdaq.
  • KindlyMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 million, down 33.0% from fiscal 2024.
  • As of September 25, 2026, NAKA traded at $9.99, a market capitalization of $177.2 million.
  • Return on equity was −20.2% and debt-to-equity 0.00.

Source: company filings (standardised) and stockrow calculations.

KindlyMD, Inc. (NAKA) Latest News

News by impact score

Fine-tune

31 Aug

4

Nakamoto CEO David Bailey asserts Bitcoin’s corporate adoption is not a betrayal and signals plans for expanded mergers and acquisitions. CEO commitment to larger M&A push represents major strategic move with potential to reshape company trajectory.

15 Jul

4

KindlyMD Inc (NAKA) stock surged on July 15 amid unspecified developments driving investor interest and trading volume. Stock surge signals major market reaction likely tied to strategic or operational catalysts that can shift investor sentiment and company trajectory.

24 Jun

5

Nasdaq-listed KindlyMD, Inc. (NAKA) is executing a drastic strategy shift to go all in on Bitcoin. All-in Bitcoin strategy will fundamentally alter NAKA's business trajectory and market perception.

23 Jun

5

KindlyMD Inc. (NAKA) closed its final healthcare clinics and shifted entirely to Bitcoin operations. Complete exit from healthcare into sole Bitcoin focus redefines KindlyMD business model and prospects.

10 Apr

4

TD Cowen identifies more than one winner in crypto treasury strategies, including KindlyMD, Inc. (NAKA). TD Cowen's endorsement of KindlyMD as a crypto treasury winner could significantly enhance investor sentiment and alter its market trajectory.

25 Feb

4

KindlyMD, Inc. (NAKA) stock plunged 41.5% over four weeks but is poised for turnaround due to key positive developments. Turnaround signals after major decline indicate significant potential boost to NAKA's trajectory and investor sentiment.

4

Nakamoto (NAKA) completes acquisition of BTC Inc., enabling UTXO Management to build an integrated Bitcoin ecosystem. Acquisition completion marks a major strategic move expanding NAKA into Bitcoin ecosystem integration, likely boosting market performance and investor sentiment.

21 Jan

4

KindlyMD, Inc. has rebranded itself as Nakamoto Inc. to emphasize its new focus on Bitcoin treasury management. This strategic shift aims to align the company's identity with the growing interest in cryptocurrency and digital assets, reflecting a commitment to leveraging Bitcoin as a key financial resource. The rebranding to Nakamoto Inc. signifies a major strategic pivot towards cryptocurrency, which could significantly alter the company's trajectory and investor sentiment.

3

KindlyMD, Inc. (NAKA) has undergone a rebranding initiative in response to a delisting threat from Nasdaq due to its stock price falling below the required minimum. The company aims to enhance its market presence and investor confidence through this strategic shift. The rebranding is part of a broader effort to stabilize operations and improve financial performance amidst challenges in the health sector. Rebranding efforts may positively influence market sentiment and operational aspects, but the overall impact is expected to be limited.

2 Jan

3

KindlyMD, Inc. (NAKA) experienced a significant surge in stock price on the first trading day of the New Year, following a challenging period for cryptocurrency-related stocks. The increase reflects a potential rebound in market sentiment towards crypto investments, which may positively influence investor confidence in NAKA's future performance. The stock surge indicates a moderate influence on market sentiment, but the overall effect on the company's trajectory remains uncertain.

18 Dec

4

Nakamoto has authorized a $10 million share repurchase program for KindlyMD, Inc. (NAKA), aiming to enhance shareholder value and potentially stabilize the stock price amid market fluctuations. The share repurchase program is a significant strategic move that could positively influence investor sentiment and the company's market performance.

4

KindlyMD, Inc. (NAKA) has announced the implementation of a share buyback program, aimed at utilizing its Bitcoin treasury to repurchase shares. This strategic move is expected to enhance shareholder value and reflects the company's confidence in its financial position and future prospects. The share buyback program indicates a significant strategic initiative that could positively influence investor sentiment and the company's market performance.

16 Dec

4

KindlyMD, Inc. (NAKA), a company associated with Bitcoin, has received a delisting notice from Nasdaq due to its failure to meet the exchange's minimum bid price requirement. This notice comes as the company's stock has struggled, raising concerns about its future on the exchange. The company has been given a 180-day period to regain compliance or face potential delisting. Receiving a delisting notice from Nasdaq significantly impacts the company's market perception and operational stability.

4

KindlyMD, Inc. (NAKA) is facing potential delisting from Nasdaq as its stock price has plummeted by 99%. The company, which has been involved in Bitcoin treasury management, is struggling to maintain compliance with Nasdaq's minimum bid price requirement. This drastic decline in stock value raises concerns about its financial stability and future operations. The potential delisting from Nasdaq could significantly impact investor sentiment and the company's operational viability.

4

KindlyMD, Inc. (NAKA) faces potential delisting from Nasdaq as its stock price falls below $1, raising concerns about its financial stability. The company, which has adopted a Bitcoin treasury strategy, is now compared to MicroStrategy (MSTR) regarding its ability to survive this financial challenge. Investors are questioning whether KindlyMD can navigate this crisis and maintain its market position amidst increasing scrutiny. The potential delisting and financial instability could significantly impact investor sentiment and the company's future operations.

4

KindlyMD, Inc. (NAKA) is at risk of being delisted from Nasdaq due to its failure to maintain the minimum share price requirement of $1. The company has been notified by the exchange and has a 180-day grace period to regain compliance. If it fails to do so, it may face delisting, which could significantly impact its market presence and investor confidence. Failure to meet Nasdaq's listing requirements poses a significant threat to the company's market position and investor sentiment.

12 Dec

4

David Bailey, CEO of KindlyMD, Inc. (NAKA), has been recognized for his influential leadership in the healthcare technology sector. Under his guidance, the company has made significant strides in developing innovative solutions aimed at improving patient care and streamlining healthcare processes. Bailey's vision and strategic direction have positioned KindlyMD as a key player in the industry, attracting attention from investors and stakeholders alike. His commitment to leveraging technology for better health outcomes has set a benchmark for others in the field. Bailey's leadership and strategic initiatives are likely to significantly influence KindlyMD's market position and investor sentiment.

10 Dec

4

Nakamoto Holdings (NAKA) has successfully refinanced its debt through a $210 million bitcoin-backed loan. This strategic move aims to improve the company's financial position and reduce interest expenses, allowing for greater flexibility in future investments and operations. The refinancing with a substantial bitcoin-backed loan is a significant strategic move that could enhance financial stability and operational flexibility.

4

KindlyMD, Inc. (NAKA) has secured a $210 million loan at an 8% interest rate, marking Kraken as its fourth provider for this financing. The loan is backed by Bitcoin, reflecting the company's strategy to leverage cryptocurrency in its financial operations. The significant loan arrangement indicates a strategic shift that could enhance financial flexibility and market positioning.

9 Dec

4

David Bailey predicts that half of the Digital Asset Trusts (DATs) will consolidate, indicating a significant shift in the market landscape. This consolidation could impact various players in the industry, including KindlyMD, Inc. (NAKA), as it navigates the evolving dynamics of digital assets and healthcare technology. The anticipated consolidation of DATs could significantly alter market dynamics and impact KindlyMD's strategic positioning.

6 Dec

3

ProCap BTC, a Bitcoin treasury firm founded by Anthony Pompliano, has successfully closed its SPAC merger deal, marking a significant milestone for the company. This merger is expected to enhance ProCap BTC's position in the cryptocurrency market and provide additional resources for growth and expansion. The deal reflects increasing interest in Bitcoin and related financial services, potentially influencing market dynamics. The SPAC merger could moderately influence ProCap BTC's financial performance and competitive positioning in the cryptocurrency sector.

21 Nov

3

KindlyMD, Inc. (NAKA) reported a high burn rate in its Q3 filing, raising concerns about its financial sustainability. The filing also highlighted significant executive compensation, which may further impact investor sentiment and perceptions of the company's management efficiency. High burn rate and executive compensation could moderately influence investor confidence and financial performance.

17 Nov

3

KindlyMD, Inc. (NAKA) has experienced a significant decline in stock value following a delay in its earnings report. The company, which has been involved in Bitcoin treasury management, is facing scrutiny as investors react to the uncertainty surrounding its financial disclosures. This situation has raised concerns about the company's operational stability and future performance in the market. The earnings delay may moderately affect investor confidence and financial performance, but the overall impact is expected to be limited.

27 Oct

3

KindlyMD, Inc. (NAKA) has been identified as one of the most active stocks in the market, indicating heightened trading activity and interest among investors. The company's stock performance reflects significant movements, which may be influenced by recent developments or market trends. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.

24 Oct

3

KindlyMD, Inc. (NAKA) has been identified as one of the most active stocks in the market, indicating heightened trading activity and interest among investors. This surge in activity may reflect broader market trends or specific developments related to the company that have captured investor attention. The increased trading volume could influence the stock's price movement and investor sentiment moving forward. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.

16 Oct

3

KindlyMD, Inc. (NAKA) faces challenges as the PIPE model in Bitcoin treasury strategies experiences a decline. The article outlines the rise of this model, which allowed companies to raise capital through private investments in public equity, but highlights the pitfalls and failures that have led to its diminished effectiveness. Factors such as market volatility and regulatory scrutiny have contributed to the model's struggles, impacting companies like KindlyMD that have engaged in these strategies. The future of such financial approaches remains uncertain as the landscape evolves. The decline of the PIPE model in Bitcoin treasury strategies may moderately influence KindlyMD's financial performance and market positioning.

14 Oct

3

Metaplanet has begun trading below 1x mNAV for the first time since initiating its Bitcoin Treasury Plan, raising concerns about its financial strategy and market positioning. This development could signal a shift in investor sentiment and market dynamics as the company navigates its cryptocurrency investments. Trading below 1x mNAV indicates potential challenges in financial performance and market perception.

10 Oct

4

KindlyMD, Inc. (NAKA) is exploring the integration of Bitcoin into its capital structure, which could potentially reshape its financial narrative. The company aims to leverage cryptocurrency to enhance liquidity and attract new investors, signaling a strategic pivot that may influence its market positioning. This move aligns with broader trends in the healthcare and technology sectors, where digital assets are gaining traction. Analysts are closely monitoring how this initiative could impact KindlyMD's operational dynamics and investor sentiment moving forward. The integration of Bitcoin into KindlyMD's capital structure could significantly alter its financial strategy and market perception.

9 Oct

3

KindlyMD, Inc. (NAKA) has reported that Two Prime has achieved a record $827 million in Bitcoin-backed loans during the third quarter. This significant milestone highlights the growing interest and investment in cryptocurrency-backed financial products, potentially positioning KindlyMD favorably in the evolving financial landscape. The increase in Bitcoin-backed loans may moderately influence KindlyMD's financial performance and market positioning.

7 Oct

4

Antalpha has provided an interim loan to KindlyMD, Inc. (NAKA) as part of a larger financial strategy involving a $250 million convertible note aimed at supporting Nakamoto's operations and growth initiatives. The interim loan and upcoming convertible note are significant financial moves that could enhance KindlyMD's operational capacity and market positioning.

stockrow.com/NAKA · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com